GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aarti Drugs Ltd (NSE:AARTIDRUGS) » Definitions » Institutional Ownership

Aarti Drugs (NSE:AARTIDRUGS) Institutional Ownership : 8.72% (As of Dec. 12, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Aarti Drugs Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Aarti Drugs's institutional ownership is 8.72%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Aarti Drugs's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Aarti Drugs's Float Percentage Of Total Shares Outstanding is 0.00%.


Aarti Drugs Institutional Ownership Historical Data

The historical data trend for Aarti Drugs's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aarti Drugs Institutional Ownership Chart

Aarti Drugs Historical Data

The historical data trend for Aarti Drugs can be seen below:

2024-02-29 2024-03-31 2024-04-30 2024-05-31 2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-11-30
Institutional Ownership 6.79 6.79 6.89 7.19 7.42 7.73 7.76 8.02 8.73 8.72

Aarti Drugs Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Aarti Drugs Business Description

Traded in Other Exchanges
Address
Road No. 29, Plot Number 109-D, Mahendra Industrial Estate, Ground Floor, Sion (East), Mumbai, MH, IND, 400022
Aarti Drugs Ltd is a pharmaceutical company. It offers active pharmaceutical ingredients (APIs), pharma intermediaries, specialty chemicals, and formulations in a range of therapeutic categories, such as anti-inflammatory, cardioprotectant, antibiotic, antidiabetic, and vitamins among others. The product offerings of the company comprise Aceclofenac, Celecoxib, Moxifloxacin, and others. The firm caters to both domestic and international markets and derives a majority of its revenue from its business in India.

Aarti Drugs Headlines

No Headlines